Stock GYRE GYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Gyre Therapeutics, Inc.

Equities

GYRE

US4037831033

Real-time Estimate Cboe BZX
Other stock markets
 02:35:33 2024-06-12 pm EDT 		5-day change 1st Jan Change
10.8 USD -0.42% Intraday chart for Gyre Therapeutics, Inc. -0.37% -57.80%
May. 31 Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy MT
May. 30 Gyre Pharmaceuticals Receives IND Approval from China?s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Gyre Therapeutics Gets Investigational New Drug Application Approval in China for Pulmonary Arterial Hypertension Therapy
MT
Gyre Pharmaceuticals Receives IND Approval from China?s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
CI
Gyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Gyre Therapeutics Swings to Fiscal 2023 Net Loss, Revenue Rises
MT
Gyre Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Gyre Therapeutics, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Reverse Split: 1 of 15
FA
Gyre Therapeutics, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GYRE Stock
  4. News Gyre Therapeutics, Inc.
  5. Highlights